IBS Clinical Trial
— HELFABOfficial title:
Health Effects and Consumer Aspects of Different Types of Bread
Verified date | October 2020 |
Source | Oslo Metropolitan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Dietary fiber is well known to have health promoting effects, including reduced blood glucose and cholesterol levels. Bread is the most important source of dietary fiber in the Norwegian diet. Production of bread has changed from the traditionally use of sourdough, to yeast (Saccharomyces cerevisiae) as the dominating leavening agent in modern industrial production. Sourdough naturally contains bacteria, and through the fermentation process these bacteria release several components that are not found in modern bread using yeast. It has been shown that sourdough may have positive health effects, including on blood glucose regulation. The aim of the project is to investigate if intake of sourdough may give positive health effects compared to beard with yeast.
Status | Completed |
Enrollment | 20 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 20, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - healthy adults who restrict their intake of bread due to stomach ache. Exclusion Criteria: - Chronic metabolic diseases, such as diabetes type 1 or 2, cardiovascular diseases and cancer last 6 months - Gut diseases, including Chron's disease, ulcers colitis - Food allergies or intolerance - Pregnant and/or lactating - Smokers - BMI <18,5 and >27 kg/m2 - Planed weight reduction and/or ± 5% weight change last 3 months - Blood donor last 2 months and during the study period - Not willing to quit taking dietary supplements, including probiotics, cod liver oil etc., 4 weeks prior to study start and during the study - Use of antibiotics <3 months prior to study start and during the study - Alcohol intake >40 g/day - Hormone treatment (except contraceptives) |
Country | Name | City | State |
---|---|---|---|
Norway | Vibeke Telle-Hansen | Oslo |
Lead Sponsor | Collaborator |
---|---|
Oslo Metropolitan University | Mesterbakeren, University of Oslo |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Gastrointestinal Symptom Rating Scale-irritable bowl syndrome (GSRS-IBS) | GSRS-IBS analysis after intervention with bread baked with yeast versus sourdough with the following response scale: 1 (no discomfort at all) to 7 (very severe discomfort) | 5 weeks | |
Secondary | Bristol stool chart (BSC) | BSC analyses after intervention with bread baked with yeast versus sourdough with a scale from 1 (separate hard lumps, like nuts) to 7 (watery, no solid pieces) | 5 weeks | |
Secondary | Blood C-peptide, total cholesterol, triglycerides, fatty acid profile, and short chain fatty acids | Blood analyses of C-peptide, total cholesterol, triglycerides, fatty acid profile, and short chain fatty acids after intervention with bread baked with yeast versus sourdough | 5 weeks | |
Secondary | Feces microbiota analysis performed with Bio-Me's Precision Microbiome Profiling platform (PMP™) | Feces analyses of microbiota after intervention with bread baked with yeast versus sourdough | 5 weeks | |
Secondary | Iron, selenium and zinc in blood | Blood analysis of iron, selenium and zinc after intervention with bread baked with yeast versus sourdough | 5 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02293343 -
24 Hrs Histamine Profile in Healthy Persons and Patients With Food Intolerance
|
N/A | |
Completed |
NCT01717404 -
Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)
|
Phase 1 | |
Withdrawn |
NCT02313207 -
Confocal Laser Endomicroscopy in IBS Patients
|
N/A | |
Completed |
NCT02937506 -
Patient Satisfaction With Propofol for Out Patient Colonoscopy
|
Phase 4 | |
Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
Completed |
NCT02419963 -
Analyzing IBS to Identify Biomarkers and Microbiome Signatures
|
N/A | |
Recruiting |
NCT06389851 -
Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD
|
N/A | |
Recruiting |
NCT05815602 -
Ebastine Versus Mebeverine in IBS Patients
|
Phase 3 | |
Completed |
NCT03482765 -
A Study of Probiotics in IBS Subjects
|
N/A | |
Completed |
NCT03986476 -
The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome
|
N/A | |
Recruiting |
NCT06275906 -
Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.
|
N/A | |
Not yet recruiting |
NCT05737277 -
Gabapral in Pediatric IBS
|
N/A | |
Active, not recruiting |
NCT05718505 -
Comparison of the Atmo Motility Gas Capsule System to the Reference Standard
|
N/A | |
Recruiting |
NCT06072287 -
The Living With a Long-Term Condition Study
|
||
Completed |
NCT04953728 -
Optimization of Transcutaneous Electrical Acustimulation (TEA) Modalities for Treatment of IBS-C
|
N/A | |
Completed |
NCT02681666 -
Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome
|
N/A | |
Completed |
NCT02981888 -
Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
|
||
Completed |
NCT01667627 -
Probiotic in Irritable Bowel Syndrome (IBS) Patients With Diarrhea
|
Phase 4 | |
Recruiting |
NCT01779765 -
The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS)
|
Phase 4 | |
Completed |
NCT02009618 -
The Effects of Rifaximin Therapy in Irritable Bowel Syndrome
|
N/A |